Announced Thu, 14 May · 17:50 IST

The NRC has granted 107700 stock options to eligible employees pursuant to ESOP 2025/ Scheme. The grant date for ESOP Grant 1 - 2026 will be 15th May 2026.

Capital Market Events View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-6.9%1-day move
₹94.00
prior close
₹97.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-4.0-2.0-2.0+2.1-6.9-6.2-4.3-2.2-1.1-1.9-4.3-4.1-5.2
Up moveDown movePending
AI summary

The Nomination and Remuneration Committee of Chemcrux Enterprises Ltd approved the grant of 107,700 stock options to eligible employees under the Chemcrux Enterprises Employee Stock Option Scheme 2025. The options have a grant date of 15th May 2026, with an exercise price of Rs. 10 per option, matching the face value of Rs. 10 per share. Each option is convertible into one fully paid equity share. The options vest 100% after one year from the grant date, subject to continued employment, and can be exercised within three years from vesting. The scheme involves a new issuance of equity shares, not secondary acquisition, and no options have been exercised yet.

Likely market impact

Existing shareholders face potential dilution of up to 107,700 equity shares (approx. 1.07 lakh shares) once all options are vested and exercised, which will increase the company's equity base. No immediate impact on earnings per share as options are not yet exercised.